Logo
x

Search

Subscribe Now

Phase

Novartis Reports Results of Kisqali in Second Phase P-III MONALEESA-3 Study for HR+/HER2- Advanced Breast Cancer in Women

Novartis Reports Results of Kisqali in Second Phase P-III MONALEESA-3 Study for HR+/HER2- Advanced Breast Cancer in Women

  • August 1, 2019
Sanofi and Alnylam Exercise Research and Option Phase Collaboration for its 2014 Deal

Sanofi and Alnylam Exercise Research and Option Phase Collaboration for its 2014 Deal

  • April 8, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.